Al-Razi Medical Co. (9572.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Al-Razi Medical Co., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | 56.50x | 491.67x | 132.51x | 27.47x | 25.58x |
| P/B Ratio | 1.97x | 3.82x | 4.06x | 2.35x | 2.29x |
| P/S Ratio | 0.62x | 1.41x | 1.48x | 1.06x | 1.22x |
| Profitability | |||||
| Gross Margin | 25.9% | 27.0% | 22.9% | 25.9% | 24.8% |
| Operating Margin | 2.1% | 0.7% | 3.0% | 5.5% | 5.9% |
| Net Margin | 1.1% | 0.3% | 1.1% | 3.8% | 4.8% |
| EBITDA Margin | 2.1% | 0.7% | 8.3% | 10.9% | 11.3% |
| Liquidity | |||||
| Current Ratio | 1.47x | 1.92x | 1.79x | 2.07x | 2.61x |
| Quick Ratio | 0.29x | 0.33x | 0.25x | 0.28x | 0.98x |
| Leverage | |||||
| Debt/Equity | 0.51x | 0.38x | 0.48x | 0.33x | 0.27x |
YoY = year-over-year change. Source: FMP..